Product Information
FLUOROURACIL 2% TOPICAL SOLN is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $3.4213 per ML under NDC 51672406201. Its NADAC has been published 567 times since Nov 28, 2013.
FDA first approved this application on Nov 5, 2003. Its Orange Book therapeutic-equivalence code is AT.
Strength
20 mg/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672406201
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
FLUOROURACILApproval Type
Generic (ANDA)
FDA Application
ANDA076526FDA Approved
11/5/2003
TE Code
AT
On Market Since
11/5/2003
Pharmacological Classes
Price Statistics
The NADAC for FLUOROURACIL 2% TOPICAL SOLN has been published 567 times since Nov 28, 2013, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.4213 per ML |
|---|---|
| All-time high | $5.3458 (May 14, 2014) |
| All-time low | $2.8623 (Nov 20, 2024) |
| 52-week high | $4.5224 |
| 52-week low | $3.4213 |
| Median price | $4.4806 |
| Average price | $4.4372 |
| Largest weekly change | -21.3% (Oct 19, 2022) |
| Weeks tracked | 567 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluorouracil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluorouracil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nucleoside Metabolic Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUOROURACIL 2% TOPICAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for FLUOROURACIL 2% TOPICAL SOLN, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $3.4213 per ML (NDC 51672406201), effective Sep 30, 2026.
How has the price of FLUOROURACIL 2% TOPICAL SOLN changed over time?
Over the history we have for it, the NADAC for FLUOROURACIL 2% TOPICAL SOLN has declined 21.1%. It has been tracked across 567 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUOROURACIL 2% TOPICAL SOLN?
Since Nov 28, 2013, the NADAC for FLUOROURACIL 2% TOPICAL SOLN has ranged from a low of $2.8623 (Nov 20, 2024) to a high of $5.3458 (May 14, 2014), with a median of $4.4806 per ML.
Are there cheaper alternatives to FLUOROURACIL 2% TOPICAL SOLN?
No other NADAC-published product currently shares the active ingredient and strength of FLUOROURACIL 2% TOPICAL SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUOROURACIL 2% TOPICAL SOLN?
FLUOROURACIL 2% TOPICAL SOLN (NDC 51672406201) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.